Teleflex Inc

Most Recent

  • uploads///TFX
    Company & Industry Overviews

    Analysts Still Bullish on Teleflex Stock

    Teleflex’s (TFX) interest expenses increased from $19.89 million in the second quarter of 2017 to $26.65 million in the second quarter of 2018.

    By Kenneth Smith
  • uploads///ABMD PE MC
    Healthcare

    Analyzing ABMD, BR, and TFX Stocks

    Abiomed’s (ABMD) net income has grown at a three-year and five-year average of 95.1% and 120.4%, respectively.

    By Amanda Lawrence
  • uploads///GROWTH INDEX EXPO TO IT
    Consumer

    Total Returns and Sector Exposure for Growth Indexes

    If we dig into the S&P 500 and the S&P Growth indexes, we can see that they have the highest exposure to information technology (or IT).

    By Amanda Lawrence
  • uploads///blood _
    Company & Industry Overviews

    Analysts’ Recommendations for Haemonetics and Peers in March 2018

    In its fiscal 3Q18, which ended on December 31, 2017, Haemonetics (HAE) reported revenue of close to $234 million.

    By Margaret Patrick
  • uploads///blood _
    Company & Industry Overviews

    What Analysts Recommend for Edwards Lifesciences

    Of the 22 analysts covering Edwards Lifesciences in February 2018, 17 analysts have given the stock a “buy” or a higher rating.

    By Kenneth Smith
  • uploads///EW revenue
    Company & Industry Overviews

    Analyzing Edwards Lifesciences’ Recent Acquisitions

    In December 2017, Edwards Lifesciences (EW) acquired Harpoon Medical for a total consideration of $119.5 million.

    By Kenneth Smith
  • uploads///MMSI revenue
    Company & Industry Overviews

    Exploring Merit Medical Systems’ Business Segments

    In 3Q17, Merit Medical Systems’ cardiovascular segment generated revenues of $172.7 million—compared to $150.5 million in 3Q16.

    By Kenneth Smith
  • uploads///doctors office checkup medical
    Company & Industry Overviews

    Merit Medical Systems: Analysts’ Ratings in February 2018

    Of the eight analysts covering Merit Medical Systems in February, four gave it a “strong buy,” three gave it a “buy,” and one gave it a “sell” rating.

    By Kenneth Smith
  • Company & Industry Overviews

    What Sector Powered FKGRX in 1Q16?

    FKGRX rose 0.2% in 1Q16. It fell 1.1% in the one-year period ended March 2016, and it was placed fourth among its peer group.

    By David Ashworth
  • uploads///Part  Graph
    Company & Industry Overviews

    IHI: Which of Its Holdings Was the Top Performer?

    In this article, we’ll analyze the YTD (year-to-date) performances of the top five holdings of the iShares US Medical Device ETF (IHI).

    By Peter Neil
  • uploads///Cumulative Flows in  Year Until November
    Company & Industry Overviews

    High-Yield Bond Mutual Funds: What to Expect in 2016

    If you’re a moderate investor invested in high-yield bond mutual funds, you could consider moving some of your assets to investment grade funds (OPIGX).

    By David Ashworth
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.